Hearing aid study explores link between better hearing and brain health

NCT ID NCT04899037

First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 2 times

Summary

This study follows 50 adults aged 18–85 with certain types of hearing loss who either use or could use an FDA-approved bone-anchored hearing device. Over 3 years, researchers will measure changes in memory, attention, and other thinking skills. The goal is to see if treating hearing loss with this device might help slow cognitive decline.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could show that treating hearing loss with an osseointegrated device helps preserve cognitive function in older adults.
What could go wrong
This is an observational pilot study with only 50 participants, so results may not apply to everyone. It does not test a new treatment, only tracks existing device users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEAFNESS, UNILATERAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of USF Health Otolaryngology; Auditory Rehabilitation & Clinical Trials Lab

    RECRUITING

    Tampa, Florida, 33613, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.